Washington, DC 20006-5349
HELPLINE
MESOTHELIOMA NEWS
Scroll to find news of interest to you, or search by category. The Mesothelioma Applied Research Foundation covers mesothelioma news for patients and their families. Our write-ups are heavily reliant on peer-reviewed medical research studies with input from mesothelioma experts from around the world but are also accessible to non-medical readers.
Last week, the Polaris Group announced positive results of its Phase 2/3 clinical trial evaluating the effectiveness of an arginine degrading enzyme agent called ADI-PEG 20.
On this Mesothelioma Awareness Day, the mesothelioma community will once again work in their local communities to light the world blue! As part of this
The Mesothelioma Applied Research Foundation is proud to announce the recipients of its most recent round of new mesothelioma research funding. Through a rigorous review
On July 22 and 23rd, the mesothelioma community once again gathered at the Mesothelioma Applied Research Foundation’s International Symposium on Malignant Mesothelioma (also known more
Today, the Mesothelioma Applied Research Foundation announced its 2022 mesothelioma award recipients for its Pioneer Award, the Klaus Brauch Above and Beyond Award, and the
For over 18 years, the International Symposium on Malignant Mesothelioma has been the go-to place for mesothelioma patients and their families to find community and
A new study just published in the journal Science challenged our collective hope that natural infection by Omicron would convey a degree of immunity that
In an analysis published last week, the Centers for Disease Control and Prevention (CDC) reported a significant increase in mesothelioma deaths among women during the
Get the latest information about mesothelioma, clinical trials, patient stories, community events, and much more!
